Establishing a Physical Activity Referral Scheme for People With Noncommunicable Diseases in the German Healthcare System (BewegtVersorgt)
Sponsor: University of Erlangen-Nürnberg
A observational or N/A phase clinical study on Non-Communicable Chronic Diseases, this trial is completed. The trial is conducted by University of Erlangen-Nürnberg and has accumulated 8 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
May 4, 2026 — Present [daily]
Completed
Status: Unknown → Completed · Phase: NA → None
-
Dec 2024 — May 2026 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2022 — Jul 2024 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Jul 2022 — Dec 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2021 — Jul 2022 [monthly]
Not Yet Recruiting NA
-
Sep 2021 — Dec 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
The BewegtVersorgt project involved co-producing a physical activity referral scheme (PARS) for inactive persons with underlying non-communicable diseases. Various relevant actors of the German healthcare system (e.g., representatives of physicians, health insurance providers, sports organizations, exercise representatives of exercise professions, representatives of patients) participated in the co-production process. The purpose of this study is to evaluate the effectiveness of co-produced PARS in the Erlangen-Nuremberg-Fürth region. Local general practitioners and exercise professionals will carry out the implementation of the PARS in standard care. The cluster-randomized study includes two intervention arms; one group will receive specific support from physical activity experts to increase physical activity (PARS). The control group will receive only the physician's advice and then continue to engage in physical activity on their own (PAA). The participants will be followed up at 12 and 24 weeks.
Contact Information
- University of Erlangen-Nürnberg
For direct contact, visit the study record on ClinicalTrials.gov .